Hub : Traits :

Medication: Paracetamol

416 significantly associated models · 38 unique genes.

Significant Loci

#	chr	p0	p1	# assoc genes	# joint genes	best TWAS P	best SNP P	cond SNP P	% var exp	joint genes
1	1	173885712	175194390	1	1	1.3e-07	2.6e-09	1.0e+00	100	RABGAP1L
2	1	242590540	244359621	3	1	6.7e-11	8.2e-11	3.3e-01	98	SDCCAG8
3	3	48618666	50448632	6	1	7.0e-08	2.5e-06	3.4e-01	96	RNF123
4	6	12020241	13990267	2	1	3.3e-08	1.8e-08	1.0e+00	100	RP1-257A7.5
5	6	25285943	26689223	1	1	1.3e-11	2.8e-13	8.8e-05	71	U91328.21
6	6	96275538	97699026	2	1	9.8e-09	8.4e-10	2.4e-02	86	KIAA0776
7	8	140969818	142706843	1	1	4.8e-08	1.3e-04	8.4e-01	100	PTK2
8	9	125444045	127385609	1	1	1.5e-07	7.8e-07	7.0e-01	99	DENND1A
9	12	56805309	58303535	2	1	1.2e-18	2.1e-18	1.0e+00	100	LRP1
10	17	42774693	45796313	19	1	4.3e-15	7.4e-15	1.0e+00	100	LRRC37A4P

Pleiotropic Associations

Trait	chisq ratio	# genes⁺	# genes⁺⁺	% genes⁺⁺	corr	corr P	genes
Bipolar Disorder or Schizophrenia	3.42	2	1	2.2	0.00	1.0e+00	SDCCAG8 U91328.21
Depressed Affect (Nagel 2018)	9.41	4	2	4.4	0.99	9.9e-03	LRRC37A4P PTK2 RNF123 SDCCAG8
Depression (Nagel 2018)	3.60	1	0	0.0	0.00	1.0e+00	LRRC37A4P
Intelligence (Savage-Jansen 2018)	5.21	4	2	4.4	-0.95	5.5e-02	LRRC37A4P PTK2 RABGAP1L RNF123
Neuroticism (Nagel 2018)	7.88	2	1	2.2	0.00	1.0e+00	LRRC37A4P RABGAP1L
Schizophrenia (2018)	4.49	2	1	2.2	0.00	1.0e+00	SDCCAG8 U91328.21
Worry (Nagel 2018)	4.39	2	1	2.2	0.00	1.0e+00	LRRC37A4P RABGAP1L
Irritable Bowel Disease (IBD)	1.91	1	1	2.2	0.00	1.0e+00	RNF123
Ulcerative Colitis (UC)	2.41	1	1	2.2	0.00	1.0e+00	RNF123
Major Depression (MDD)	2.62	1	0	0.0	0.00	1.0e+00	RNF123
Verbal and Numeric Reasoning (VNR)	4.76	3	2	4.4	0.00	1.0e+00	LRRC37A4P RNF123 U91328.21
Breast Cancer	3.68	1	1	2.2	0.00	1.0e+00	LRRC37A4P
Ovarian Cancer	5.40	1	1	2.2	0.00	1.0e+00	LRRC37A4P
Prostate Cancer	3.05	1	0	0.0	0.00	1.0e+00	RNF123
Age at First Birth	4.53	1	1	2.2	0.00	1.0e+00	RNF123
Coronary Artery Disease (CAD)	5.15	1	1	2.2	0.00	1.0e+00	RP1-257A7.5
Neuroticism (2016)	4.96	1	1	2.2	0.00	1.0e+00	LRRC37A4P
Primary Biliary Cirrhosis	3.47	2	0	0.0	0.00	1.0e+00	LRP1 LRRC37A4P
Schizophrenia (2014)	2.49	1	0	0.0	0.00	1.0e+00	SDCCAG8
Ulcerative Colitis	2.31	1	0	0.0	0.00	1.0e+00	RNF123
Blood Eosinophil Count	2.66	2	2	4.4	0.00	1.0e+00	LRP1 LRRC37A4P
Blood Platelet Count	0.63	1	0	0.0	0.00	1.0e+00	LRRC37A4P
Blood Red Count	6.38	3	2	4.4	0.00	1.0e+00	LRRC37A4P RABGAP1L RP1-257A7.5
Blood White Count	1.63	3	1	2.2	0.00	1.0e+00	LRRC37A4P PTK2 RNF123
Heel T-Score	2.26	3	1	2.2	0.00	1.0e+00	DENND1A LRRC37A4P RNF123
BMI	2.84	4	1	2.2	-0.41	5.9e-01	DENND1A LRP1 RABGAP1L RNF123
Height	0.92	2	2	4.4	0.00	1.0e+00	LRP1 LRRC37A4P
Waist Hip Ratio (WHR)	3.69	3	1	2.2	0.00	1.0e+00	LRRC37A4P PTK2 RNF123
Systolic Blood Pressure	3.21	4	3	6.7	-0.76	2.4e-01	KIAA0776 LRRC37A4P RP1-257A7.5 SDCCAG8
Smoking Status	3.64	2	1	2.2	0.00	1.0e+00	PTK2 RNF123
Allergy or Eczema	1.96	1	0	0.0	0.00	1.0e+00	LRP1
Cardiovascular Disease	1.71	1	0	0.0	0.00	1.0e+00	SDCCAG8
Hypothyroidism (self reported)	1.76	1	0	0.0	0.00	1.0e+00	PTK2
Respiratory disease	3.45	2	1	2.2	0.00	1.0e+00	LRP1 RABGAP1L
Lung FEV1/FVC ratio	4.47	3	2	4.4	0.00	1.0e+00	LRP1 LRRC37A4P RNF123
Lung FVC	6.25	2	2	4.4	0.00	1.0e+00	LRRC37A4P RNF123
Neuroticism	8.55	3	1	2.2	0.00	1.0e+00	LRRC37A4P RABGAP1L RNF123
Chronotype (morning person)	2.34	2	0	0.0	0.00	1.0e+00	DENND1A RNF123
Hair Pigment	0.31	3	1	2.2	0.00	1.0e+00	DENND1A LRP1 LRRC37A4P
Hand grip strength (left)	3.02	2	2	4.4	0.00	1.0e+00	LRRC37A4P RP1-257A7.5
Number of treatments/medications taken	7.38	4	0	0.0	0.97	2.6e-02	LRP1 RABGAP1L RNF123 SDCCAG8
Sensitivity / hurt feelings	7.16	1	1	2.2	0.00	1.0e+00	LRRC37A4P
Frequency of depressed mood in last 2 weeks	3.89	1	0	0.0	0.00	1.0e+00	LRRC37A4P
Hearing difficulty/problems: Yes	2.93	1	1	2.2	0.00	1.0e+00	PTK2
Relative age of first facial hair	7.60	1	1	2.2	0.00	1.0e+00	LRRC37A4P
Systolic blood pressure, automated reading	3.50	3	1	2.2	0.00	1.0e+00	KIAA0776 LRRC37A4P RP1-257A7.5
Angina	2.94	1	1	2.2	0.00	1.0e+00	RP1-257A7.5
Vitamin and mineral supplements	4.76	1	1	2.2	0.00	1.0e+00	LRP1
Impedance of leg (right)	2.07	3	2	4.4	0.00	1.0e+00	LRRC37A4P PTK2 RNF123
Leg fat-free mass (left)	1.31	1	0	0.0	0.00	1.0e+00	RNF123
Trunk fat percentage	2.32	2	0	0.0	0.00	1.0e+00	DENND1A LRRC37A4P
Hand grip strength (right)	2.81	3	1	2.2	0.00	1.0e+00	LRP1 LRRC37A4P RP1-257A7.5
Fed-up feelings	6.83	2	2	4.4	0.00	1.0e+00	LRRC37A4P RNF123
Relative age voice broke	4.95	1	1	2.2	0.00	1.0e+00	LRRC37A4P
Taking other prescription medications	3.00	1	0	0.0	0.00	1.0e+00	RNF123
Age when periods started (menarche)	2.79	2	1	2.2	0.00	1.0e+00	LRRC37A4P RNF123
Heel bone mineral density (BMD) T-score, automated (left)	1.56	1	0	0.0	0.00	1.0e+00	LRRC37A4P
High blood pressure	3.47	3	0	0.0	0.00	1.0e+00	LRRC37A4P PTK2 SDCCAG8
Hayfever, allergic rhinitis or eczema	1.55	1	0	0.0	0.00	1.0e+00	LRP1
Multivitamins +/- minerals	2.45	1	0	0.0	0.00	1.0e+00	LRP1
Sitting height	2.40	2	2	4.4	0.00	1.0e+00	LRP1 LRRC37A4P
Body mass index (BMI)	2.64	2	1	2.2	0.00	1.0e+00	DENND1A RNF123
Impedance of leg (left)	2.48	3	2	4.4	0.00	1.0e+00	LRRC37A4P PTK2 RNF123
Leg predicted mass (left)	1.31	1	0	0.0	0.00	1.0e+00	RNF123
Trunk fat mass	2.04	3	0	0.0	0.00	1.0e+00	DENND1A LRRC37A4P RNF123
Waist circumference	1.77	1	0	0.0	0.00	1.0e+00	DENND1A
Past tobacco smoking	2.79	1	0	0.0	0.00	1.0e+00	RNF123
Alcohol usually taken with meals	3.18	1	0	0.0	0.00	1.0e+00	RABGAP1L
Nervous feelings	4.01	1	1	2.2	0.00	1.0e+00	LRRC37A4P
Frequency of tenseness / restlessness in last 2 weeks	6.55	2	1	2.2	0.00	1.0e+00	LRRC37A4P RNF123
Hearing difficulty/problems with background noise	3.14	1	0	0.0	0.00	1.0e+00	LRRC37A4P
Hair/balding pattern: Pattern 2	3.35	1	0	0.0	0.00	1.0e+00	LRRC37A4P
Forced vital capacity (FVC)	6.29	3	2	4.4	0.00	1.0e+00	LRRC37A4P RNF123 U91328.21
Ever unenthusiastic/disinterested for a whole week	4.24	2	0	0.0	0.00	1.0e+00	LRRC37A4P RNF123
Qualifications: None of the above	4.69	2	1	2.2	0.00	1.0e+00	PTK2 RNF123
Mouth/teeth dental problems	4.26	2	0	0.0	0.00	1.0e+00	PTK2 SDCCAG8
Heart attack	5.79	1	1	2.2	0.00	1.0e+00	RP1-257A7.5
Allergy	2.04	1	0	0.0	0.00	1.0e+00	LRP1
Pain all over the body in last month	2.27	1	0	0.0	0.00	1.0e+00	RNF123
Hayfever/allergic rhinitis (self-reported)	2.78	1	0	0.0	0.00	1.0e+00	LRP1
Fluid intelligence score	4.22	2	0	0.0	0.00	1.0e+00	RNF123 U91328.21
Neuroticism score	7.20	2	1	2.2	0.00	1.0e+00	LRRC37A4P RABGAP1L
Weight	1.82	2	1	2.2	0.00	1.0e+00	DENND1A RNF123
Impedance of arm (right)	3.20	2	2	4.4	0.00	1.0e+00	LRRC37A4P RNF123
Arm fat percentage (right)	1.80	2	0	0.0	0.00	1.0e+00	DENND1A RNF123
Trunk fat-free mass	1.47	2	1	2.2	0.00	1.0e+00	RABGAP1L RNF123
Hip circumference	1.79	1	0	0.0	0.00	1.0e+00	RNF123
Time employed in main current job	3.02	1	0	0.0	0.00	1.0e+00	LRRC37A4P
Worrier / anxious feelings	2.53	1	1	2.2	0.00	1.0e+00	LRRC37A4P
Frequency of tiredness / lethargy in last 2 weeks	4.08	1	0	0.0	0.00	1.0e+00	RNF123
Hair/balding pattern: Pattern 3	5.70	1	1	2.2	0.00	1.0e+00	LRRC37A4P
Number of live births	2.06	1	0	0.0	0.00	1.0e+00	LRRC37A4P
Forced expiratory volume in 1-second (FEV1)	7.50	3	3	6.7	0.00	1.0e+00	LRRC37A4P RNF123 U91328.21
Qualifications: A levels/AS levels or equivalent	4.90	3	1	2.2	0.00	1.0e+00	LRRC37A4P RNF123 SDCCAG8
Mouth/teeth dental problems: Dentures	3.19	1	0	0.0	0.00	1.0e+00	RNF123
Asthma	3.88	2	0	0.0	0.00	1.0e+00	LRP1 U91328.21
Medication: Ibuprofen (e.g. Nurofen)	13.86	5	2	4.4	0.98	3.0e-03	KIAA0776 LRP1 LRRC37A4P RP1-257A7.5 U91328.21
Forced expiratory volume in 1-second (FEV1), Best measure	6.97	3	3	6.7	0.00	1.0e+00	LRRC37A4P RNF123 U91328.21
Pulse wave Arterial Stiffness index	2.67	1	0	0.0	0.00	1.0e+00	RP1-257A7.5
Impedance of arm (left)	3.54	2	2	4.4	0.00	1.0e+00	LRRC37A4P RNF123
Arm fat mass (right)	1.94	2	1	2.2	0.00	1.0e+00	DENND1A RNF123
Trunk predicted mass	1.44	4	1	2.2	-0.17	8.3e-01	LRP1 PTK2 RABGAP1L RNF123
Standing height	0.95	3	2	4.4	0.00	1.0e+00	LRP1 LRRC37A4P U91328.21
Exposure to tobacco smoke at home	2.45	1	0	0.0	0.00	1.0e+00	RNF123
Tense / 'highly strung'	3.68	1	1	2.2	0.00	1.0e+00	RABGAP1L
Seen doctor (GP) for nerves, anxiety, tension or depression	3.48	1	0	0.0	0.00	1.0e+00	U91328.21
Hair/balding pattern: Pattern 4	10.69	1	1	2.2	0.00	1.0e+00	LRRC37A4P
Birth weight of first child	2.91	1	1	2.2	0.00	1.0e+00	PTK2
Peak expiratory flow (PEF)	4.43	2	1	2.2	0.00	1.0e+00	LRRC37A4P U91328.21
Ever highly irritable/argumentative for 2 days	2.56	1	0	0.0	0.00	1.0e+00	RNF123
Qualifications: O levels/GCSEs or equivalent	2.75	1	0	0.0	0.00	1.0e+00	RNF123
Headache pain in last month	28.96	7	6	13.3	0.95	1.1e-03	KIAA0776 LRP1 LRRC37A4P RABGAP1L RP1-257A7.5 SDCCAG8 U91328.21
Hypothyroidism/myxoedema (self-reported)	2.01	1	0	0.0	0.00	1.0e+00	PTK2
Birth weight	2.47	1	0	0.0	0.00	1.0e+00	PTK2
Forced vital capacity (FVC), Best measure	5.75	3	2	4.4	0.00	1.0e+00	LRRC37A4P RNF123 U91328.21
Body fat percentage	2.37	2	0	0.0	0.00	1.0e+00	DENND1A LRP1
Leg fat percentage (right)	3.02	3	1	2.2	0.00	1.0e+00	DENND1A LRP1 RNF123
Arm fat-free mass (right)	1.52	1	1	2.2	0.00	1.0e+00	RNF123
Exposure to tobacco smoke outside home	4.70	2	0	0.0	0.00	1.0e+00	DENND1A SDCCAG8
Comparative body size at age 10	1.45	1	0	0.0	0.00	1.0e+00	U91328.21
Worry too long after embarrassment	2.77	1	0	0.0	0.00	1.0e+00	LRRC37A4P
Wheeze or whistling in the chest in last year	3.76	1	0	0.0	0.00	1.0e+00	RNF123
Age at first live birth	3.86	1	1	2.2	0.00	1.0e+00	RNF123
Pulse wave peak to peak time	2.54	1	0	0.0	0.00	1.0e+00	RP1-257A7.5
Qualifications: College or University degree	7.75	5	4	8.9	-0.97	4.8e-03	LRRC37A4P PTK2 RABGAP1L RNF123 SDCCAG8
Medication for pain relief, constipation, heartburn	19.69	9	6	13.3	-0.99	4.9e-07	DENND1A KIAA0776 LRP1 LRRC37A4P PTK2 RABGAP1L RP1-257A7.5 SDCCAG8 U91328.21
Neck or shoulder pain in last month	4.23	1	0	0.0	0.00	1.0e+00	PTK2
Angina (self-reported)	2.90	1	1	2.2	0.00	1.0e+00	RP1-257A7.5
Migraine (self-reported)	18.49	3	3	6.7	0.00	1.0e+00	KIAA0776 LRP1 RP1-257A7.5
Medication: Ibuprofen	10.66	3	2	4.4	0.00	1.0e+00	LRP1 LRRC37A4P RP1-257A7.5
Heart disease (mother)	3.30	1	0	0.0	0.00	1.0e+00	RP1-257A7.5
Whole body fat mass	2.14	2	1	2.2	0.00	1.0e+00	DENND1A RNF123
Leg fat mass (right)	2.69	2	1	2.2	0.00	1.0e+00	DENND1A RNF123
Arm predicted mass (right)	1.67	1	1	2.2	0.00	1.0e+00	RNF123
Pulse rate, automated reading	2.13	2	0	0.0	0.00	1.0e+00	RNF123 RP1-257A7.5
Alcohol intake frequency.	4.49	3	1	2.2	0.00	1.0e+00	LRP1 LRRC37A4P RP1-257A7.5
Comparative height size at age 10	1.51	2	2	4.4	0.00	1.0e+00	LRRC37A4P U91328.21
Suffer from 'nerves'	2.57	1	0	0.0	0.00	1.0e+00	LRRC37A4P
Overall health rating	5.27	2	2	4.4	0.00	1.0e+00	RNF123 SDCCAG8
Chest pain or discomfort	1.84	1	0	0.0	0.00	1.0e+00	RNF123
Age at last live birth	3.51	1	1	2.2	0.00	1.0e+00	RNF123
Knee pain experienced in last month	5.42	3	0	0.0	0.00	1.0e+00	PTK2 RABGAP1L SDCCAG8
Hypertension (Self-reported)	3.21	2	0	0.0	0.00	1.0e+00	PTK2 SDCCAG8
Illnesses of father: Heart disease	4.38	1	1	2.2	0.00	1.0e+00	RP1-257A7.5
Whole body fat-free mass	1.40	1	1	2.2	0.00	1.0e+00	RNF123
Leg fat-free mass (right)	1.24	1	0	0.0	0.00	1.0e+00	RNF123
Arm fat percentage (left)	1.84	2	0	0.0	0.00	1.0e+00	DENND1A RNF123
Handedness (chirality/laterality): Left-handed	3.37	1	1	2.2	0.00	1.0e+00	LRRC37A4P
Mood swings	7.98	3	2	4.4	0.00	1.0e+00	LRRC37A4P PTK2 RNF123
Loneliness, isolation	3.08	1	0	0.0	0.00	1.0e+00	LRRC37A4P
Mouth/teeth dental problems: Mouth ulcers	4.32	1	1	2.2	0.00	1.0e+00	LRRC37A4P
Medication for cholesterol	1.95	1	0	0.0	0.00	1.0e+00	LRRC37A4P
Back pain experienced in last month	3.97	1	0	0.0	0.00	1.0e+00	PTK2
Mineral and other dietary supplements	2.61	1	0	0.0	0.00	1.0e+00	LRP1
Asthma (self-reported)	3.71	2	0	0.0	0.00	1.0e+00	LRP1 U91328.21
Osteoarthritis (self-reported)	3.27	1	0	0.0	0.00	1.0e+00	PTK2
Forced expiratory volume in 1-second (FEV1), predicted percentage	7.42	3	2	4.4	0.00	1.0e+00	LRRC37A4P RNF123 U91328.21
Whole body water mass	1.44	1	1	2.2	0.00	1.0e+00	RNF123
Leg predicted mass (right)	1.22	2	0	0.0	0.00	1.0e+00	PTK2 RNF123
Arm fat mass (left)	1.86	2	1	2.2	0.00	1.0e+00	DENND1A RNF123
Average weekly champagne plus white wine intake	3.74	1	0	0.0	0.00	1.0e+00	LRRC37A4P
Miserableness	7.15	3	2	4.4	0.00	1.0e+00	LRRC37A4P RNF123 SDCCAG8
Guilty feelings	4.86	2	1	2.2	0.00	1.0e+00	LRRC37A4P RNF123
Financial situation satisfaction	2.90	1	0	0.0	0.00	1.0e+00	RNF123
Medication: Blood pressure	2.80	1	1	2.2	0.00	1.0e+00	LRRC37A4P
Supplements: Fish oil (including cod liver oil)	2.94	1	0	0.0	0.00	1.0e+00	LRP1
Medication: Paracetamol	20.23	10	6	13.3	0.99	4.8e-09	DENND1A KIAA0776 LRP1 LRRC37A4P PTK2 RABGAP1L RNF123 RP1-257A7.5 SDCCAG8 U91328.21
Ever smoked	2.54	1	0	0.0	0.00	1.0e+00	RNF123
Basal metabolic rate	1.44	1	1	2.2	0.00	1.0e+00	RNF123
Leg fat percentage (left)	2.97	3	1	2.2	0.00	1.0e+00	DENND1A LRP1 RNF123
Arm fat-free mass (left)	1.63	1	1	2.2	0.00	1.0e+00	RNF123
Number of operations (self-reported)	4.11	1	0	0.0	0.00	1.0e+00	RNF123
Average weekly beer plus cider intake	3.22	1	0	0.0	0.00	1.0e+00	RNF123
Irritability	3.74	1	1	2.2	0.00	1.0e+00	LRRC37A4P
Risk taking	2.61	1	0	0.0	0.00	1.0e+00	SDCCAG8
Ever had prostate specific antigen (PSA) test	2.41	1	0	0.0	0.00	1.0e+00	U91328.21
Diastolic blood pressure, automated reading	5.23	2	2	4.4	0.00	1.0e+00	SDCCAG8 U91328.21
Ever depressed for a whole week	3.07	1	0	0.0	0.00	1.0e+00	RNF123
Myopia	4.15	1	0	0.0	0.00	1.0e+00	LRP1
Vascular/heart problems diagnosed by doctor	2.68	2	0	0.0	0.00	1.0e+00	PTK2 SDCCAG8
Pain experienced in last month	9.72	5	1	2.2	-0.99	1.2e-03	LRP1 LRRC37A4P PTK2 RABGAP1L RNF123
Heart attack/myocardial infarction (self-reported)	5.76	1	1	2.2	0.00	1.0e+00	RP1-257A7.5
Heart disease (siblings)	3.72	1	1	2.2	0.00	1.0e+00	RP1-257A7.5
Impedance of whole body	3.30	3	3	6.7	0.00	1.0e+00	LRRC37A4P PTK2 RNF123
Leg fat mass (left)	2.62	2	1	2.2	0.00	1.0e+00	DENND1A RNF123
Arm predicted mass (left)	1.67	2	1	2.2	0.00	1.0e+00	RABGAP1L RNF123

Associations by panel

study	tissue	# hits	% hits/tests	avg chisq
GTEx	Adipose Subcutaneous	9	0.258	1.7
GTEx	Adipose Visceral Omentum	6	0.295	1.8
GTEx	Adrenal Gland	5	0.343	1.7
GTEx	Artery Aorta	11	0.369	1.8
GTEx	Artery Coronary	10	0.845	2.1
GTEx	Artery Tibial	10	0.266	1.8
GTEx	Brain Caudate basal ganglia	6	0.652	1.7
GTEx	Brain Cerebellar Hemisphere	6	0.403	1.7
GTEx	Brain Cerebellum	7	0.353	1.8
GTEx	Brain Cortex	7	0.676	1.8
GTEx	Brain Frontal Cortex BA9	6	0.649	1.8
GTEx	Brain Hippocampus	4	0.763	1.9
GTEx	Brain Hypothalamus	4	0.678	1.9
GTEx	Brain Nucleus accumbens basal ganglia	6	0.694	1.9
GTEx	Brain Putamen basal ganglia	5	0.801	2.0
GTEx	Breast Mammary Tissue	9	0.456	1.8
GTEx	Breast Mammary Tissue (Male)	7	0.587	1.8
GTEx	Breast Mammary Tissue (Female)	8	0.487	1.8
GTEx	Cells EBV-transformed lymphocytes	9	0.632	1.9
GTEx	Cells Transformed fibroblasts	10	0.238	1.7
GTEx	Colon Sigmoid	7	0.479	1.9
GTEx	Colon Transverse	9	0.436	1.8
GTEx	Esophagus Gastroesophageal Junction	8	0.554	1.9
GTEx	Esophagus Mucosa	11	0.331	1.7
GTEx	Esophagus Muscularis	11	0.340	1.8
GTEx	Heart Atrial Appendage	8	0.507	1.7
GTEx	Heart Left Ventricle	7	0.458	1.7
GTEx	Liver	4	0.558	1.8
GTEx	Lung	9	0.313	1.7
GTEx	Muscle Skeletal	8	0.277	1.7
GTEx	Nerve Tibial	9	0.208	1.7
GTEx	Ovary	6	0.661	1.9
GTEx	Pancreas	7	0.429	1.9
GTEx	Pituitary	5	0.448	1.8
GTEx	Prostate	5	0.599	1.9
GTEx	Skin Not Sun Exposed Suprapubic	8	0.325	1.8
GTEx	Skin Sun Exposed Lower leg	9	0.247	1.8
GTEx	Small Intestine Terminal Ileum	4	0.868	2.0
GTEx	Spleen	5	0.354	1.7
GTEx	Stomach	7	0.481	1.8
GTEx	Testis	10	0.317	1.8
GTEx	Thyroid	10	0.250	1.7
GTEx	Uterus	6	1.058	2.1
GTEx	Vagina	5	0.787	2.0
GTEx	Whole Blood	6	0.301	1.7
METSIM	Adipose	2	0.043	1.5
NTR	Blood	4	0.167	1.6
ROSMAP	Brain Pre-frontal Cortex	0	0.000	1.6
YFS	Blood	0	0.000	1.5
CommonMind	Brain Pre-frontal Cortex	4	0.074	1.5
The Cancer Genome Atlas	Bladder Urothelial Carcinoma	3	0.181	1.6
The Cancer Genome Atlas	Breast Invasive Carcinoma	2	0.045	1.5
The Cancer Genome Atlas	Cervical Squamous Cell Carcinoma	3	0.273	1.6
The Cancer Genome Atlas	Colon Adenocarcinoma	1	0.048	1.4
The Cancer Genome Atlas	Esophageal Carcinoma	3	0.438	1.7
The Cancer Genome Atlas	Glioblastoma Multiforme	1	0.098	1.6
The Cancer Genome Atlas	Head and Neck Squamous Cell Carcinoma	2	0.073	1.5
The Cancer Genome Atlas	Kidney Renal Clear Cell Carcinoma	6	0.146	1.5
The Cancer Genome Atlas	Kidney Renal Papillary Cell Carcinoma	2	0.098	1.5
The Cancer Genome Atlas	Brain Lower Grade Glioma	4	0.093	1.5
The Cancer Genome Atlas	Liver Hepatocellular Carcinoma	3	0.271	1.5
The Cancer Genome Atlas	Lung Adenocarcinoma	5	0.170	1.6
The Cancer Genome Atlas	Lung Squamous Cell Carcinoma	4	0.160	1.6
The Cancer Genome Atlas	Ovarian Serous Cystadenocarcinoma	4	0.251	1.5
The Cancer Genome Atlas	Pancreatic Adenocarcinoma	4	0.241	1.6
The Cancer Genome Atlas	Pheochromocytoma and Paraganglioma	4	0.301	1.6
The Cancer Genome Atlas	Prostate Adenocarcinoma	8	0.173	1.5
The Cancer Genome Atlas	Rectum Adenocarcinoma	3	0.434	1.6
The Cancer Genome Atlas	Soft Tissue Sarcoma	4	0.375	1.6
The Cancer Genome Atlas	Skin Cutaneous Melanoma	1	0.187	1.6
The Cancer Genome Atlas	Stomach Adenocarcinoma	3	0.178	1.5
The Cancer Genome Atlas	Testicular Germ Cell Tumors	1	0.078	1.5
The Cancer Genome Atlas	Thyroid Carcinoma	4	0.078	1.5
The Cancer Genome Atlas	Uterine Corpus Endometrial Carcinoma	2	0.394	1.6